20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with Kidney Diseases in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Hasegawa, Y; Hirata, T; Inatani, S; Kojima, N; Koretsune, H; Ohara, H; Takahashi, T | 1 |
| Ito, D; Ito, O; Kohzuki, M; Miura, T; Muroya, Y; Ogawa, Y; Sakuyama, A; Takahashi, J; Xu, L | 1 |
| Chesnik, MA; Hye Khan, MA; Imig, JD; Kolb, LL; Skibba, M; Yeboah, MM | 1 |
| Fan, F; Muroya, Y; Roman, RJ | 1 |
| Falck, JR; Ledbetter, SR; Manthati, VL; McMullen, ME; Regner, KR; Roman, RJ; Ryan, RP; Shames, BD; Van Why, SK; Zuk, A | 1 |
| Boonprasert, K; Na-Bangchang, K; Ruengweerayut, R; Satarug, S | 1 |
| Doi, M; Ishimoto, T; Miyata, N; Roman, RJ; Sakurai, T; Sato, M; Seki, T; Taniguchi, K; Yasuda, Y | 1 |
1 review(s) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Kidney Diseases
| Article | Year |
|---|---|
Cytochrome P450 eicosanoids in hypertension and renal disease.
Topics: Arachidonic Acids; Blood Vessels; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 4; Eicosanoids; Humans; Hydroxyeicosatetraenoic Acids; Hypertension; Kidney Diseases; Kidney Tubules; Sodium | 2015 |
6 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Kidney Diseases
| Article | Year |
|---|---|
Renoprotective Effect of TP0472993, a Novel and Selective 20-Hydroxyeicosatetraenoic Acid Synthesis Inhibitor, in Mouse Models of Renal Fibrosis.
Topics: Animals; Disease Models, Animal; Fibrosis; Kidney; Kidney Diseases; Mice; Mice, Inbred C57BL; Nephritis; Renal Insufficiency, Chronic; Ureteral Obstruction | 2023 |
Exercise training delays renal disorders with decreasing oxidative stress and increasing production of 20-hydroxyeicosatetraenoic acid in Dahl salt-sensitive rats.
Topics: Animals; Antihypertensive Agents; Arachidonic Acid; Blood Pressure; Fibrosis; Hydroxyeicosatetraenoic Acids; Hypertension; Kidney; Kidney Diseases; Male; Oxidative Stress; Physical Conditioning, Animal; Rats; Rats, Inbred Dahl; Sodium Chloride; Sodium Chloride, Dietary; Thiobarbituric Acid Reactive Substances | 2020 |
Role of the cytochrome P-450/ epoxyeicosatrienoic acids pathway in the pathogenesis of renal dysfunction in cirrhosis.
Topics: Animals; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme System; Hydroxyeicosatetraenoic Acids; Kidney Diseases; Liver Cirrhosis; Male; Rats; Rats, Sprague-Dawley; Signal Transduction | 2018 |
Protective effect of 20-HETE analogues in experimental renal ischemia reperfusion injury.
Topics: Animals; Hydroxyeicosatetraenoic Acids; Kidney Diseases; Kidney Medulla; Kidney Tubules; Protective Agents; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Reperfusion Injury; Sodium | 2009 |
Study on the association between environmental cadmium exposure, cytochrome P450-mediated 20-HETE, heme-oxygenase-1 polymorphism and hypertension in Thai population residing in a malaria endemic areas with cadmium pollution.
Topics: Adult; Arachidonic Acid; Cadmium; Cytochrome P-450 Enzyme System; Endemic Diseases; Environmental Exposure; Environmental Monitoring; Environmental Pollution; Epidemiological Monitoring; Female; Heme Oxygenase-1; Humans; Hydroxyeicosatetraenoic Acids; Hypertension; Kidney Diseases; Kidney Function Tests; Malaria; Male; Middle Aged; Polymorphism, Genetic; Smoking; Thailand | 2011 |
Increased excretion of urinary 20-HETE in rats with cyclosporine-induced nephrotoxicity.
Topics: Animals; Blood Urea Nitrogen; Creatinine; Cyclosporine; Cytochrome P-450 CYP4A; Drug Administration Schedule; Gene Expression; Hydroxyeicosatetraenoic Acids; Injections, Intraperitoneal; Kidney Cortex; Kidney Diseases; Male; Rats; Rats, Sprague-Dawley; Time Factors; Urine; Urodynamics | 2005 |